GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a major focus in healthcare research, largely due to its impressive impact on treating conditions such as adult-onset diabetes and obesity. Ongoing trials have revealed that beyond glucose regulation, GLP-1 drugs offer